Aug 4 (Reuters) – The U.S. Drug Enforcement Administration
(DEA) on Friday proposed a 20 percent reduction in the
manufacture of certain commonly prescribed opioid painkillers as
well as other controlled substances for next year.

Read More At Article Source | Article Attribution